Literature DB >> 32965311

Hemophagocytic syndrome: a potential COVID-19 complication.

Lucas Tadashi Wada Amaral1, Eduardo Kaiser Ururahy Nunes Fonseca1, Márcia Jacomelli2, Gilberto Szarf1, Rodrigo Caruso Chate1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32965311      PMCID： PMC7572271          DOI： 10.36416/1806-3756/e20200296

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN： 1806-3713            Impact factor:   2.624


× No keyword cloud information.
  3 in total

1.  Cytokine release syndrome in severe COVID-19.

Authors:  John B Moore; Carl H June
Journal:  Science       Date:  2020-04-17       Impact factor: 47.728

2.  A Hemophagocytic Lymphohistiocytosis Case with Newly Defined UNC13D (c.175G>C; p.Ala59Pro) Mutation and a Rare Complication.

Authors:  Yasemin Işık Balcı; Funda Özgürler Akpınar; Aziz Polat; Fethullah Kenar; Bianca Tesi; Tatiana Greenwood; Nagihan Yalçın; Ali Koçyiğit
Journal:  Turk J Haematol       Date:  2015-09-28       Impact factor: 1.831

3.  Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19.

Authors:  Stanislas Faguer; Arnaud Del Bello; Florence Abravanel; Marie-Laure Nicolau-Travers; Nassim Kamar
Journal:  Ann Intern Med       Date:  2020-05-18       Impact factor: 25.391
  3 in total
  1 in total

Review 1.  Haemophagocytic syndrome and COVID-19.

Authors:  Soledad Retamozo; Pilar Brito-Zerón; Antoni Sisó-Almirall; Alejandra Flores-Chávez; María-José Soto-Cárdenas; Manuel Ramos-Casals
Journal:  Clin Rheumatol       Date:  2021-01-03       Impact factor: 2.980
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.